Evidence map›Paper›PMID 31685515›Full record

ArticleBMJ open2019

Scoping review protocol documenting cancer outcomes and inequalities for adults living with intellectual and/or developmental disabilities.

Morgan Stirling, Janice Linton, Hélène Ouellette-Kuntz, Shahin Shooshtari, Julie Hallet, Christine Kelly, David Dawe, Mark Kristjanson, Kathleen Decker, Alyson Mahar

Abstract read
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Morgan StirlingDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-4286-0688
Janice LintonDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Hélène Ouellette-KuntzDepartment of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
Shahin ShooshtariDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Julie HalletDepartment of Surgery, University of Toronto, Toronto, Ontario, Canada.
Christine KellyDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
David DaweInternal Medicine, University of Manitoba College of Medicine, Winnipeg, Manitoba, Canada.
Mark KristjansonCommunity Oncology Program, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
Kathleen DeckerDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Alyson MaharDepartment of Community Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada alyson_mahar@cpe.umanitoba.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is increasing attention on the cancer burden for adults with intellectual and developmental disabilities (IDD). Emerging evidence suggests there are differences in cancer experiences and outcomes for individuals living with IDD, from risk through survivorship. These differences may be attributed to features of the IDD, such as cognitive deficits and communication, as well as social determinants of health-like lower education levels and ableism. However, there is no comprehensive overview of the literature quantifying these potential disparities and describing the influencing factors. In this paper, we describe a scoping review protocol to systematically review published literature on cancer for adults with IDD. The purpose of this review is to identify differences in cancer risk, stage at diagnosis, treatment and survival along the cancer continuum for adults with IDD and outline potential contributing factors creating these disparities. METHODS AND ANALYSIS: We will follow Arksey and O'Malley's expanded framework for scoping reviews to conduct this review. We will systematically search electronic databases for peer-reviewed, published journal articles to identify appropriate studies in collaboration with a health science librarian. Two reviewers will independently review titles and abstracts followed by a full-text review to determine whether it meets inclusion criteria. A data chart for collecting and sorting information will be developed in consultation with the team. Results will be collated and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews: PRISMA-Scoping Reviews. Extracted information will be summarised quantitatively and qualitatively to meet review objectives. ETHICS AND DISSEMINATION: This scoping review will employ a methodology to identify literature related to cancer outcomes and experiences for adults with IDD. Results will be disseminated to relevant stakeholders who care for and support individuals with IDD at local, provincial and national levels and through publishing findings. By highlighting the disparities in the cancer system and gaps in the research, this scoping review can provide direction for future action.

Indexed as

Healthcare DisparitiesSocial Determinants of HealthAdultBiomedical ResearchDevelopmental DisabilitiesHumansIntellectual DisabilityNeoplasmsNeoplasm StagingPrognosisRisk FactorsScoping Reviews as TopicTreatment Outcomecancercancer outcomeshealth disparitieshealth equityintellectual and developmental disabilities

Identifiers

PMID31685515
PMCPMC6858132

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.